id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1995-E-0065-0001,FDA,FDA-1995-E-0065,Determination of Regulatory Review Period for Purposes of Patent Extension; SERZONE®,Notice,Determinations,1995-04-27T04:00:00Z,1995,4,1995-04-24T04:00:00Z,1995-06-24T03:59:59Z,2017-10-13T13:51:35Z,95-10077,0,0,090000648056cd01